Trials / Conditions / Metabolic-dysfunction-associated Fatty Liver Disease (MAFLD)
Metabolic-dysfunction-associated Fatty Liver Disease (MAFLD)
4 registered clinical trials studyying Metabolic-dysfunction-associated Fatty Liver Disease (MAFLD) — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly NCT07068191 | Phenomen Pharma | N/A |
| Recruiting | A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-assoc NCT06884293 | Innovent Biologics (Suzhou) Co. Ltd. | Phase 3 |
| Enrolling By Invitation | Optimal Measurement of Spleen Stiffness Among Veterans With Metabolic Dysfunction-Associated Steatotic Liver D NCT06953830 | William Jennings Bryan Dorn VA Medical Center | N/A |
| Completed | Noninvasive Assessment of Metabolic Associated Fatty Liver Disease (MAFLD) in Chinese Population NCT04551716 | Chinese PLA General Hospital | — |